As Pfizer's stock surged Monday, Albert Bourla netted $5.6M in stock sales
On Monday morning, Pfizer announced they had developed the first effective Covid-19 vaccine, the world celebrated, their stock jumped 13% and their CEO became $5.6 million richer.
In an SEC filing Tuesday, Pfizer CEO Albert Bourla disclosed he sold off 132,508 shares at the peak of the Monday surge for $41.92 a piece. Bourla’s sale is kosher because it was planned and pre-approved in August for when the stock hit a certain price, but it adds the Big Pharma chief to the list of executives who have drawn scrutiny for selling shares as their company’s Covid-19 efforts progressed and stocks rose.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 94,100+ biopharma pros reading Endpoints daily — and it's free.